The application of cognitive-behavioural therapy for depression to people with human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS).
Over the past decade the cognitive approach to depression has received considerable attention. The impetus for this stems from empirical and theoretical reports of its efficacy in its application to the treatment of depressed individuals (Beck, 1976, 1976; Seligman, 1975; Abramson et al., 1978). This paper examines the theory and practice of cognitive behavioural therapy (CBT) and questions whether it has anything to offer clinicians working with people affected by acquired immune deficiency syndrome (AIDS) or the human immunodeficiency virus (HIV) given that it was originally developed, and has traditionally been used, to treat mood disordered psychiatric patient populations. The theory of cognitive therapy is examined with specific emphasis on Beck's contribution. Reference is made to the literature on the psychological problems experienced by people with AIDS (PWAs), and an assessment is presented of the contribution of cognitive therapy to ameliorate problems experienced by PWAs.
Church
J
J
Courtyard Clinic, St. George's Healthcare NHS Trust, London, UK.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000523:psychology*; D000223:Adaptation, Psychological; D001007:Anxiety; D015928:Cognitive Behavioral Therapy; D003863:Depression; D005260:Female; D006679:HIV Seropositivity / Q000523:psychology; D006801:Humans; D008297:Male; D019964:Mood Disorders / Q000628:therapy*; D019452:Terminally Ill / Q000523:psychology